|
|
Article: Fourth quarter 2002 earnings reported by supplier of human health, bioscience products.
- Article from:
- Drug Week
- Article date:
- February 21, 2003
CopyrightCOPYRIGHT 2003 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
2003 FEB 21 - (NewsRx.com & NewsRx.net) -- Cambrex Corporation (CBM) reported fourth quarter 2002 earnings of $3.0 million, or $10.4 million excluding special items recorded in the quarter, compared with $11.9 million in the fourth quarter 2001, excluding special items and amortization to reflect the adoption of SFAS 142.
Diluted earnings per share were $0.11 for the fourth quarter 2002, or $0.40 excluding the special items, versus $0.45 in the fourth quarter 2001 excluding special items.
Cambrex recorded $9.7 million in special items, pre-tax, in the fourth quarter of 2002. All items have been charged to operating expense. The items include:
...